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We compared implant and patient survival following intraoperative periprosthetic femoral fractures 
(IOPFF) during primary total hip arthroplasty (THA) with matched controls.
 
Methods 
This retrospective cohort study compared 4831 hips with IOPFF and 48154 propensity score matched 
primary THAs without IOPFF implanted between 2004 and 2016. Implant and patient survival rates 
were compared between groups using Cox regression. 
Results 
10-year stem survival was worse in the IOPFF group (p<0.001). Risk of revision for aseptic loosening 
increased 7.2 fold following shaft fracture and almost 2.8 fold after trochanteric fracture (p<0.001). 
Risk of periprosthetic fracture of the femur revision increased 4.3 fold following calcar-crack and 3.6 
fold after trochanteric fracture (p<0.01). Risk of instability revision was 3.6 fold after trochanteric 
fracture and 2.4 fold after calcar crack (p<0.001). Risk of 90-day mortality following IOPFF without 
revision was 1.7 fold and 4.0 fold after IOPFF with early revision surgery versus uncomplicated THA 
(p<0.001). 
Conclusions
IOPFF increases risk of stem revision and mortality up to 10 years following surgery. The risk of 
revision depends on IOPFF subtype and mortality risk increases with subsequent revision surgery. 
Surgeons should carefully diagnose and treat IOPFF to minimise fracture progression and implant 
failure.
 IOPFF increases risk of stem revision and mortality up to 10-years following surgery. 
 The risk of revision depends on IOPFF subtype and mortality risk increases with subsequent 
revision surgery.
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Total hip arthroplasty (THA) is a highly successful procedure with a low complication rate. One 
significant complication is intraoperative periprosthetic femoral fracture (IOPFF). IOPFF can occur in 
the trochanteric region, calcar or femoral diaphysis1. The incidence of IOPFF in primary THA ranges 
from 1–5%2-4. Most IOPFF occur during canal preparation and stem implantation 2, when the 
circumferential strains of the proximal femur are highest5, especially when the surgeon establishes 
implant stability through press-fit fixation with cementless implants6. Treatment of IOPFF is specific 
to fracture type and stability 7. Calcar cracks are commonly treated with cerclage wires or cables8, 9, 
shaft fractures with internal fixation and/or revision to a distally fixed stem2 and unstable trochanteric 
fractures with wiring or plating2, 10. 
Case series have reported excellent outcomes with appropriately treated IOPFF11, 12. More recently 
however, IOPFF has been linked to an increased risk of post-operative periprosthetic femoral fracture 
(PFF) and higher revision risk2, 8, 13, 14.  Any revision surgery also increases 30-day and 90-day 
mortality 15, but the specific effect of IOPFF on mortality has not yet been estimated.
The purpose of this study was to estimat  implant and patient survival rates following IOPFF 
compared to a matched cohort of patients undergoing uncomplicated primary THA using data from 
the National Joint Registry (NJR) for England and Wales, the world’s largest joint registry. 
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The NJR records patient and surgical data for all THAs performed at hospitals in England and Wales 
since 2003; with overall missing data estimated at 5.8%16. Surgeon-reported IOPFF, have been 
collected since 1st April 2004. This study investigated all primary stemmed THAs in the NJR from 1st 
April 2004 to 30th September 2016.
Participants
793976 THAs were eligible for analysis. Exclusions were; missing follow-up data (n = 15), cases 
from the Isle of Man (low numbers, n= 153) and where the bearing type was not a combination of 
metal on polyethylene (MoP), ceramic on polyethylene (CoP), ceramic on ceramic (CoC) or metal on 
metal (MoM) (n = 12 566).  The resulting subset of data included 781 242 primary THAs. 
Institutional ethical approval was granted for this study.
Variables
All variables relating to patient age, sex, ASA grade (1-2 vs 3-5), year of surgery, side, surgical 
approach (anterolateral [Hardinge, anterolateral and lateral], trochanteric osteotomy, posterior, other), 
computer guided surgery, minimally invasive surgery, surgeon grade (consultant/non-consultant), 
hospital type, indication, stem fixation type, bearing combination and type of thromboprophylaxis 
were included.  We included IOPFF reported as either “calcar crack”, “shaft fracture”, “shaft 
penetration”, “trochanteric fracture” and text describing IOPFF in “other”. Cases were grouped as 
calcar, trochanter or shaft fractures.
Outcomes
The primary outcomes were implant survival and patient survival. Implant survival was estimated 
until stem-only revision (all stem attributable revisions: Aseptic stem loosening [ASL], instability, 
PFF, pain, infection, stem fracture, stem malalignment) and separately for revisions indicated for PFF, 
instability, ASL and infection. Implants which were not revised during follow up were censored. 
Patient survival was estimated from primary surgery until death using pre-existing NJR data from the 
Office for National Statistics database, which provides data on all-cause patient mortality, using 
unique patient identifiers.
Statistical analysis:
Comparisons of continuous variables were performed with two-way analysis of variance for non-
normally distributed data, and categorical variables were compared with chi-square tests. Since the 
dataset was large and multiple comparisons were made, a significance level of p <0.01 was chosen. 
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The proportional hazards assumptions were satisfied for all analyses. All analyses were performed 
using R (V 3.5.1, Vienna, Austria).
Influence of IOPFF on implant survival
Propensity scores were used to match patients who sustained IOPFF (IOPFF group) to similar patients 
without IOPFF (Control group) at a ratio of 1:10 with a 0.04 standard deviation calliper matching 
width. Propensity scores was generated using logistic regression and represented the probability that a 
patient sustained IOPFF during primary THA. Variables used for matching were selected using a 
previously established model and included: age, gender, ASA grade, diagnosis, side of surgery, lead 
surgeon grade, organisation type, computer guided surgery, approach, stem fixation and bearing 
combination. Adequate balance of the IOPFF vs control group was assumed when the standardized 
mean difference (SMD) was <10% for each variable. Implant survival at up to 10-years was estimated 
using the Kaplan-Meier method and survival difference between IOPFF and controls was assessed 
using a log-rank test. Estimation of implant survival was assessed for each revision indication. 
Kaplan-Meier plots were assessed visually to identify the time period in which a difference in revision 
rate occurred between IOPFF and controls. The influence of IOPFF on implant survival during this 
period was assessed using univariate Cox regression models to estimate the adjusted hazard ratio with 
95% confidence interval (HR [95%CI]) of revision for those with IOPFF compared to controls. 
Multivariable regression was utilised for subtypes of IOPFF, which were adjusted for age, gender, 
ASA score, indication for surgery, bearing combination and stem fixation to reduce confounding 
error.
Influence of IOPFF on patient survival
Unadjusted patient survival was estimated up to 10 years using the Kaplan-Meier method and 
compared between IOPFF and no IOPFF groups using a log-rank test. Cases were coded according to 
whether the patient has an IOPFF and subsequent revision. Multivariable Cox regression models were 
used to assess the influence of IOPFF on mortality, which were adjusted for age, gender, ASA score, 
indication for surgery, bearing combination, approach, stem fixation and thromboprophylaxis17. 
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Following exclusions the overall prevalence of IOPFF was 0.62% (4833/781 242). The prevalence of 
IOPFF during cemented stem implantation was 0.87% (2969/ 341 115) for cementless stems and 
0.42% (1864/ 440 127). Only two cases in the IOPFF group could not be appropriately matched. 
Matching was achieved at a ratio of close to 1:10 within the parameters of the matching algorithm. 
Matching resulted in 4831 hips in the IOPFF group and 48154 hips in the control group. Good 
balance between IOPFF and control groups was achieved (SMD <8.3%, table 1).  Median (IQR) 
follow-up time in IOPFF and control groups were similar (5.4 years [3.2 - 8.1] versus 5.5 years [3.2 - 
8.3], p=0.305). Follow up ranged from 0.0 to 13.9 years in both groups. In the IOPFF group the 
prevalence of stem only revision in the five-years following THA was significantly higher than in the 
control group (3.01% versus 2.01%, p<0.001). 
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Influence of IOPFF on implant survival
Ten-year implant survival for stem revision was significantly worse in the IOPFF group compared to 
controls (95.4% [94.5 – 96.2] versus 96.8% [96.6 – 97.1], p<0.001). The survival difference between 
IOPFF and controls became apparent within the first 6 months and gradually increased up to ten years 
(figure 1). Relative hazard of stem revision in the first six months due to IOPFF versus no IOPFF was 
2.6 (CI 2.0 – 3.4, p<0.001). Adjusted risk of stem revision within six months versus no IOPFF was 
greatest with trochanteric fracture (HR = 3.0 [CI 1.9 – 4.8], p<0.001) followed by shaft fracture (HR = 
2.9 [CI 1.2 – 7.1], p=0.018) and calcar crack (HR = 2.4 [CI 1.7 – 3.3]. p<0.001) (figure 6).
Ten-year implant survival until revision for ASL was significantly worse in the IOPFF group 
compared to controls (99.0% [CI 98.7 – 99.4] versus 99.3% (99.2 – 99.4), p=0.004). The implant 
survival difference between IOPFF and controls became apparent within the first six months and 
steadily increased to five years (figure 2). Risk of revision in the first five years for aseptic loosening 
associated with any IOPFF versus no IOPFF was 2.1 fold (HR 2.1 [CI 1.3 – 3.2] p=0.001). The 
adjusted risk of stem revision for ASL within five years versus no IOPFF was greatest following shaft 
fracture (HR 7.2 [CI 2.9 – 17.7], p<0.001) followed by trochanteric fracture (HR 2.8 [CI 1.3 – 5.9], 
p=0.01) and least likely post calcar crack (HR 1.5 [CI 0.8 – 2.7], p=0.200) (figure 6).
Ten-year implant survival until stem revision for PFF was significantly worse in the IOPFF group 
compared to controls (98.8% [98.4 – 99.2] versus 99.4% [99.3 – 99.5], p<0.001). The survival 
difference between IOPFF and controls became apparent within the first 6 months and maintained a 
similar trend up to ten years (figure 3). Hazard ratio of revision for PFF over 6 months for any IOPFF 
versus no IOPFF was 4.2% (CI 2.7 – 6.5, p<0.001). The adjusted HR of revision within 6 months for 
PFF versus no IOPFF was greatest following shaft fracture (HR 4.4 [CI 1.1 – 18.1], p<0.039) then 
calcar crack (HR 4.3 [2.6 – 7.2], p<0.001) and finally trochanteric fracture (HR 3.6 [CI 1.6 – 8.3], 
p=0.003) (figure 6).
 Ten-year implant survival for revision for instability was significantly worse in the IOPFF group 
compared to controls (98.7% (CI 98.3 – 99.2) versus 99.2% (99.1- 99.3), p<0.001). The survival 
difference between IOPFF and controls became apparent within the first 6 months and maintained a 
similar trend subsequently, up to ten years (figure 4). Risk of revision for instability associated with 
IOPFF versus no IOPFF within 6 months was almost three-fold (HR 2.7 [CI 1.8 – 4.2] p<0.001). 
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Adjusted risk of revision for instability versus no IOPFF within 6 months was greatest with 
trochanteric fractures (HR 3.6 [CI 1.8 – 6.9], p<0.001) then calcar cracks (HR 2.4 [CI 1.4 – 4.2], 
p=0.001) and then shaft fractures (HR 1.5 [CI 0.2 – 10.7], p=0.690) (figure 6).
Ten-year implant survival for revision for infection was not significantly different in the IOPFF group 
compared to controls (99.2% (CI 98.8 – 99.6) versus 99.4% (99.3- 99.5), p<0.20) (figure 5). Risk of 
revision for instability associated with IOPFF versus no IOPFF was not statistically significant over 
the ten year period (HR 1.3 [CI 0.9 – 2.0] p= 0.184). Adjusted risk of revision for instability versus no 
IOPFF over ten years was not statistically significant for calcar cracks (HR 1.3 [CI 0.8 – 2.1], 
p=0.37), shaft fractures (HR 3.0 [CI 0.0 – infinite], p=0.99) or trochanteric fractures (HR 1.7 [CI 0.9 – 
3.2], p=0.11) (figure 6).
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Influence of IOPFF on patient survival
Unadjusted six month patient mortality was 1.7% for patients with IOPFF and 0.9% for patients 
without IOPFF. Unadjusted ten-year patient mortality was also significantly worse in the IOPFF 
group compared to controls (29.9% [CI 27.0 – 30.8] versus 25.7% [CI 25.1 – 26.3], p<0.001). The 
survival difference between IOPFF and controls became apparent within the first 6 months and very 
slowly increased up to ten years (figure 7). 
Estimated hazard of mortality during first six months post-operatively associated with IOPFF versus 
no IOPFF was 1.8 (CI 1.4 – 2.2, p<0.001). The adjusted HR of death within 90 days for patients with 
IOPFF who did not go onto revision versus patients with no IOPFF or revision surgery was 1.7 (CI 
1.3 – 2.2, p<0.001). The adjusted risk of death within 90 days for patients with IOPFF who went onto 
revision within 90 days versus patients with no IOPFF and no revision surgery was 4.0 (CI 1.5 – 10.5, 
p <0.001). 
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This is the largest study assessing patient and implant survival following intra-operative femoral 
fracture sustained during primary THA. Patients with IOPFF incur a higher risk of revision compared 
to those without IOPFF and the risk of revision is related to the specific IOPFF subtype. Patients with 
IOPFF have almost double the risk of death at six months, compared to those without IOPFF. Patients 
who require early revision following IOPFF have a four-fold risk of dying within 90 days. 
IOPFF and stem survival
Stem survival was worse for all possible revision end points with the exception of revision for 
infection following IOPFF compared to matched controls. The risk of all revision was 2.6 times the 
risk of controls for all cause stem revision, which is similar to other studies14.  IOPFF increased the 
risk of early revision for all causes and specifically for PFF, aseptic loosening and instability. 
Thillemann found that the risk of unspecified IOPFF which underwent intraoperative fixation had a 
seven-fold relative risk of revision for instability during the initial six-month period14. We found that 
the relative risk of revision for instability was four-fold higher with IOPFF. The risk was highest 
following trochanteric and calcar fractures. Trochanteric fractures can lead to reduced function of the 
hip muscles, stem subsidence and loss of stem version18. Calcar fractures may compromise the 
primary stability during surgery leading to stem subsidence over time which may slacken periarticular 
structures and lead to instability19, 20.
IOPFF have previously been linked to increased risk of revision for periprosthetic fracture9, 14. In this 
study, IOPFF led to significantly worse ten-year implant survival and a greater than 3.5 fold increase 
in the risk of PFF revision within the first six months. The greatest risk was following calcar crack, 
which increased the risk of PFF revision within six months by over four-fold. Early PFF revision may 
be the result of fixation failure with fracture propagation due to either physiological loading or a new 
injury. Calcar crack has previously been suggested to be an innocuous injury when treated 
appropriately8, 21. The true extent of calcar cracks can be difficult to fully identify during primary 
surgery, which may lead to inappropriate internal fixation. This may be due to reluctance to expose 
the proximal femur fully and difficulty identifying fractures on intraoperative radiographs because 
there is no fracture separation when the implant is removed or the femur is difficult to assess when a 
rasp or implant remains implanted. Use of plastic stem replicas intraoperatively may make the full 
extent of calcar fractures more obvious on intraoperative radiographs.
IOPFF was associated with a significantly worse 10-year ASL revision rate. Unsurprisingly, shaft 
fracture increased the risk of ASL revision seven-fold, probably because of the reduced ability of the 
surgeon to generate adequate fracture stability to withstand large hoop stresses generated by 
cementless and cemented implants, loss of stability may lead to failure of osseointegration in 
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cementless implants and loss of mantle integrity around cemented implants.   Current guidance 
advocates the use of a distally fixed stem when adequate proximal fixation is not achieved10. It is not 
possible from this study to ascertain whether such guidance was implemented. Interestingly calcar 
cracks did not lead to a significantly increased risk of five year ASL revision. This suggests that 
calcar cracks which are not revised for other causes do not lead to long term implant. It may be that 
cases with calcar cracks are more likely to be revised for PFF revision within the first few months 
rather than ASL at a later date. Trochanteric IOPFF were associated with an almost three-fold 
increase in risk of five year ASL revision. Hip muscle dysfunction may increase the resultant peak 
contact forces and joint reaction force measured in implanted femoral stems22, increasing the stress on 
the implant-bone interface and the likelihood of failure. Trochanteric fractures may also reduce 
proximal stability if the trochanteric fracture fragment includes a part of the distal metaphysis which 
may normally stabilise the upper stem body.
This study did not show any difference in rates of revision for infection between patients sustaining an 
IOPFF and matched controls. This is surprising given the expected increase in operating time that 
might be expected following an IOPFF, which has previously been linked to an increased risk of 
infection 23. A failure to demonstrate any difference in rates of infections between groups may be due 
to a lack of adequate controls in this observational study which prevent matching on other important 
factors such as antibiotic prophylaxis.
Patient survival following IOPFF
Patient survival in the IOPFF group was significantly worse up to 10-years after primary surgery. The 
difference in survival was evident most markedly within the first six months post-operatively, where 
the risk of dying within 6 months increased almost two-fold for an  IOPFF when adjusting for all 
other available factors17. When modelling the interaction of IOPFF and subsequent revision surgery 
within six months, patients with IOPFF and no stem revision surgery had double the risk of dying 
versus those without IOPFF or revision surgery. This demonstrates that part of the excess mortality 
may come from the IOPFF as a result of increased blood loss, prolonged surgery, reduced mobility 
and longer hospital stay. Part of the excess mortality in the IOPFF group may be due to increased 
revision burden since patients who had IOPFF and subsequent stem revision had a four-fold increased 
risk of dying versus no IOPFF or revision in the first six months. 
Limitations
Whilst registry data is crucial to the investigation of outcomes following uncommon complications 
the results show association between recorded variables and observed outcomes and do not 
necessarily represent causation. Confirmation of causation should be sought using the breadth of good 
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clinical research findings. THA is very successful and further advances are likely to take the form of 
small incremental changes. Despite this, large numbers included in this study increased statistical 
power and may have led to results which are statistically significant but do not reach a levels of 
clinical significance and as such should be viewed within the overall clinical context by experienced 
clinicians. The NJR records self-reported intraoperative fractures and the results are subject to 
reporting bias such that fractures not evident to the surgeon or not reported by the surgeon may be 
missed. The latter may have the effect of increasing the severity of fractures in the IOPFF group if 
there was a tendency to only report the worst fractures and increasing the likelihood that a fracture 
was included in the control group. We have used matching with regression but we are unable to 
determine the cause of death and as a result we are unable to directly ascribe the increased risk of 
death to the IOPFF or subsequent revision, even though the link between revision surgery and excess 
mortality has previously been established15. We are unable to review radiographs to establish fracture 
patterns, and treatment modalities. We assumed that the treatments given to hips in this study 
represented normal practice but we could not control for the effect of surgeon treatment choice on 
outcomes following IOPFF. These data do however represent “average” results for the “average” 
surgeon. Propensity score matching achieved excellent balance between groups but may not have 
controlled for unobserved characteristics which were important for both stem and patient survival. We 
were unable to adjust for all the relevant factors which determine post-operative mortality and implant 
failure since our data did not include radiographic or detailed co-morbidity information and as a result 
we are likely to be subject to errors due to confounding factors. In addition a small proportion of 
patients will experience implant failure without undergoing revision surgery (for example, 
conservative treatment or fixation of periprosthetic fracture) and as such will not be recorded in the 
NJR. Our approach might be improved with data linkage to hospital and primary care records. It is 
likely that linkage to patient reported outcome measures would further illuminate the true effect of 
IOPFF on patient outcomes. 
Conclusions
We have demonstrated that IOPFF is associated with an increased risk of stem revision, revision for 
ASL, PFF, instability and patient mortality following primary THA. The risk of revision was 
dependent on IOPFF subtype, and the effect of IOPFF subtype is unique to each mode of failure. We 
have also demonstrated that patients with IOPFF have a higher risk of mortality than those without 
IOPFF, and this effect appears to be comprised of both an independent risk of IOPFF to the patient 
and the subsequent risk of revision surgery. Whilst the absolute risk of death is still low, it is clear that 
surgeons should make every effort to reduce the risk of IOPFF during primary THA through careful 
selection of implants and methods. Vigilant identification and treatment of IOPFF is recommended to 
prevent implant failure and reduce associated excess patient mortality. Further work to improve 
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methods of IOPFF identification on plain radiographs is required. When IOPFF does occur patients 
should be counselled regarding the increased risk of implant failure, revision operations and mortality.
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Table 1. Non-matched and matched cohort comparison
 Unmatched SMD Matched SMD
Group: No IOPFF IOPFF  No IOPFF IOPFF  
n 776409 4833  48154 4831  
IOPFF subtype:     
None (%) 776409 (100.0)  48154 (100.0)  
Calcar crack (%)  3018 (62.4)   3017 (62.5)  
Shaft fracture (%)   340 ( 7.0)    340 ( 7.0)  
Trochanteric fracture (%)  1475 (30.5)   1474 (30.5)  
Patient Gender:   
Female (%) 475029 ( 61.2)  3560 (73.7) 0.269* 35552 ( 73.8)  3558 (73.6) 0.004
Mean age: years (range):  69.25 (11 - 117) 68.26 (12 - 105) 0.083 68.27 (12 - 102) 68.25 (15 - 98) 0.001
Age group:  0.161*  0.083
11 <50 (%)  38225 (  4.9)   390 ( 8.1)   3282 (  6.8)   390 ( 8.1)  
50 <60 (%)  95318 ( 12.3)   672 (13.9)   6570 ( 13.6)   672 (13.9)  
60 <70 (%) 231378 ( 29.8)  1324 (27.4)  14300 ( 29.7)  1324 (27.4)  
70 <80 (%) 279469 ( 36.0)  1543 (31.9)  15997 ( 33.2)  1543 (31.9)  
80 <117 (%) 132019 ( 17.0)   904 (18.7)   8005 ( 16.6)   902 (18.7)  
Side:   
Right (%) 426349 ( 54.9)  2564 (53.1) 0.037 25716 ( 53.4)  2563 (53.1) 0.007
ASA grade:  0.158*  0.017
1 - Fit and healthy (%) 117874 ( 15.2)   729 (15.1)   7086 ( 14.7)   729 (15.1)  
2 - Mild disease not incapacitating (%) 534690 ( 68.9)  3046 (63.0)  30718 ( 63.8)  3046 (63.1)  
3 - Incapacitating systemic disease (%) 119598 ( 15.4)  1007 (20.8)   9842 ( 20.4)  1005 (20.8)  
4 - Life threatening disease (%)   4129 (  0.5)    49 ( 1.0)    482 (  1.0)    49 ( 1.0)  
5 - Expected to die within 24hrs  (%)    118 (  0.0)     2 ( 0.0)     26 (  0.1)     2 ( 0.0)  
Indication for surgery:  0.276*  0.022
Acute trauma including hip fracture (%)  21685 (  2.8)   146 ( 3.0)   1426 (  3.0)   146 ( 3.0)  
Avascular necrosis (%)  10293 (  1.3)   123 ( 2.5)   1180 (  2.5)   123 ( 2.5)  
Previous trauma (%)   6974 (  0.9)   168 ( 3.5)   1535 (  3.2)   166 ( 3.4)  
Inflammatory arthritis (%)   8394 (  1.1)    99 ( 2.0)    993 (  2.1)    99 ( 2.0)  
Malignancy (%)    312 (  0.0)     3 ( 0.1)     27 (  0.1)     3 ( 0.1)  
Osteoarthritis (%) 717258 ( 92.4)  4103 (84.9)  41082 ( 85.3)  4103 (84.9)  
Other (%)   5651 (  0.7)    68 ( 1.4)    660 (  1.4)    68 ( 1.4)  
Paediatric disease (%)   5185 (  0.7)   108 ( 2.2)   1132 (  2.4)   108 ( 2.2)  
Previous arthrodesis (%)    236 (  0.0)     2 ( 0.0)     17 (  0.0)     2 ( 0.0)  
Previous infection (%)    421 (  0.1)    13 ( 0.3)    102 (  0.2)    13 ( 0.3)  
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 Table 1 continued Unmatched SMD Matched  SMD 
Approach:  0.055  0.005
Posterior (%) 447506 ( 57.6)  2669 (55.2)  26541 ( 55.1)  2669 (55.2)  
Anterolateral (%) 292455 ( 37.7)  1923 (39.8)  19218 ( 39.9)  1921 (39.8)  
Trochanteric osteotomy (%)   2986 (  0.4)    13 ( 0.3)    121 (  0.3)    13 ( 0.3)  
Other (%)  33462 (  4.3)   228 ( 4.7)   2274 (  4.7)   228 ( 4.7)  
Lead surgeon grade:   
Non consultant (%) 134866 ( 17.4)   847 (17.5) 0.004  8582 ( 17.8)   847 (17.5) 0.008
Organisation Type:  0.204*  0.009
National health service (%) 529370 ( 68.2)  3726 (77.1)  36959 ( 76.8)  3724 (77.1)  
Independent Hospital (%) 214471 ( 27.6)   984 (20.4)   9975 ( 20.7)   984 (20.4)  
Treatment centre (%)  32568 (  4.2)   123 ( 2.5)   1220 (  2.5)   123 ( 2.5)  
Stem fixation:   
Cementless (%) 338158 ( 43.6)  2969 (61.4) 0.364* 29524 ( 61.3)  2967 (61.4) 0.002
Surgical technique:   
Minimally invasive surgery (%)  53589 (  6.9)   336 ( 7.0) 0.002  3340 (  6.9)   336 ( 7.0) 0.001
Computer guided surgery   (%)    20965 (  2.7)    77 ( 1.6) 0.076   788 (  1.6)    77 ( 1.6) 0.003
Thromboprophylaxis:   
Aspirin   (%)     93989 ( 12.1)   443 ( 9.2) 0.095  5187 ( 10.8)   443 ( 9.2) 0.053
LMWH   (%)    542559 ( 69.9)  3414 (70.6) 0.016 34048 ( 70.7)  3414 (70.7) 0.001
Pentasaccharide   (%)      8785 (  1.1)    62 ( 1.3) 0.014   512 (  1.1)    62 ( 1.3) 0.02
Warfarin   (%)      9539 (  1.2)    67 ( 1.4) 0.014   606 (  1.3)    67 ( 1.4) 0.011
Direct ThrombinInhibitor   (%)     57713 (  7.4)   415 ( 8.6) 0.042  3510 (  7.3)   415 ( 8.6) 0.048
Factor Xa Inhibitor   (%)     36140 (  4.7)   203 ( 4.2) 0.022  2118 (  4.4)   203 ( 4.2) 0.01
Other chemical prophylaxis (%)     53797 (  6.9)   367 ( 7.6) 0.026  3569 (  7.4)   365 ( 7.6) 0.005
Footpump   (%)    204865 ( 26.4)  1212 (25.1) 0.03 12155 ( 25.2)  1212 (25.1) 0.004
TED   (%)    506125 ( 65.2)  3142 (65.0) 0.004 31412 ( 65.2)  3141 (65.0) 0.005
Calf compression stocking (%)    304285 ( 39.2)  1987 (41.1) 0.039 19215 ( 39.9)  1986 (41.1) 0.025
Note: All results are sum total in group with percentage of variable total in parentheses apart from age which is also given as a mean with range. SMD = If SMD is <10% acceptable balance achieved. * = SMD >0.1. 
Stanadised mean difference, ASA = American Society of Anesthesiologists grade (pre-operative), LMWH = Low molecular weight Heparin, 
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Figure 1. Kaplan–Meier plot demonstrating femoral implant survival to all cause stem revision following THA 
with IOPFF versus matched controls over 10 years. Note: p = survival comparison using log-rank test. 
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Figure 2. Kaplan–Meier plot demonstrating femoral implant survival to revision for aseptic loosening 
following THA with IOPFF versus matched controls over 10 years. Note: p = survival comparison using log-
rank test. 
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Figure 3. Kaplan–Meier plot demonstrating femoral implant survival to PFF revision following THA with IOPFF 
versus matched controls over 10 years. Note: p = survival comparison using log-rank test. 
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Figure 4. Kaplan–Meier plot demonstrating femoral implant survival to instability revision following THA with 
IOPFF versus matched controls over 10 years. Note: p = survival comparison using log-rank test. 
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Figure 5. Kaplan–Meier plot demonstrating femoral implant survival to infection revision following THA with 
IOPFF versus matched controls over 10 years. Note: p = survival comparison using log-rank test. 
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Figure 6. Hazard ratios of different indications for stem revision for each IOPFF type versus propensity 
matched controls. Note: Hazard ratio vs control group displayed with 95% confidence intervals on a 
logarithmic scale. PFF = Periprosthetic fracture of the femur. ASL = Aseptic loosening of the femoral stem. 
Hazard ratio is IOPFF vs no IOPFF in the first six months apart from ASL, where hazard ratio represents 
increased risk over the first five years and infection, where hazard is estimated over the course of ten years. 
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Figure 7. Kaplan–Meier plot demonstrating patient survival to death following THA with IOPFF versus 
matched controls over 10 years. Note: p = survival comparison using log-rank test. 
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